Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration



Status:Terminated
Conditions:Chronic Pain, Hematology
Therapuetic Areas:Hematology, Musculoskeletal
Healthy:No
Age Range:2 - 17
Updated:4/5/2017
Start Date:March 2002
End Date:August 2008

Use our guide to learn which trials are right for you!

Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study

St. Jude Children's Research Hospital is studying the best ways to prevent pain during and
after procedures such as bone marrow aspiration and lumbar puncture with intrathecal (in the
spinal fluid) chemotherapy. Researchers will study the effectiveness of combining
anesthetics (medicines that help people sleep) and analgesics (medicines that relieve pain).
Researchers believe that a combination of fentanyl (analgesic) and propofol (anesthetic),
along with applying the skin-numbing-cream EMLA or L.M.X4™ on the area where the procedure
is performed, will provide better pain control.

Each patient enrolled on this study will have three different anesthetic combinations for
three different procedures, in order to determine which combination worked best for each
child.

The study focusses on the following primary aims:

- To compare 0.5 mg/kg versus 1.0 mg/kg of fentanyl to control pain in patients who have
a BMT/LPIT procedure in the context of propofol anesthesia and topical anesthesia with
EMLA or L•M•X 4™cream (or when necessary, lidocaine for injection).

- To compare placebo versus fentanyl (0.5 mg/kg or 1.0 mg/kg) in these same patients. The
first BMT/LPIT for which patients receive any fentanyl will be used in this comparison.

The study focusses on the following secondary aims:

- To determine which dose regimen ensures best conditions to perform bone marrow
aspiration (lack of motion) and maintains hemodynamic and respiratory stability as
indicators of adequate levels of analgesia during bone marrow aspiration.

- To evaluate the safety and complications for each dose regimen.

Inclusion Criteria:

- Patients undergoing bone marrow aspiration (unilateral), with lumbar puncture and
intrathecal chemotherapy.

- Age 2 to 17 years

- ASA I-III

- Patients with acute lymphoblastic leukemia or lymphoblastic lymphoma in remission or
on the day of anticipated remission procedures occurring at the end of remission
induction.

- Patients must have three anticipated bone marrow aspirates and lumbar punctures with
intrathecal chemotherapy remaining in their treatment

Exclusion Criteria:

- Newly diagnosed patients

- Patients with low platelet count (less than 50000)

- Patients undergoing bone marrow biopsy in addition to bone marrow aspiration

- Age less than 2 years or over 17 years

- ASA IV-V

- Patients taking opioid medication for pre-existent pain for more than 2 weeks at the
time of the procedure

- Neurological impairment that would increase susceptibility to opioids (Down's
syndrome)

- Clinical contraindications for general anesthesia (large mediastinal mass) or
specific use of propofol, Fentanyl, EMLA, L•M•X 4™ or Lidocaine for injection
We found this trial at
1
site
262 Danny Thomas Pl
Memphis, Tennessee 38105
(901) 495-3300
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
?
mi
from
Memphis, TN
Click here to add this to my saved trials